Codiak BioSciences, Inc.
CDAKDelisted May 2, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001659352
Codiak BioSciences, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on Mar 30, 2023; 27 institutions reported holding it in 13F filings for Q1 2023, worth $1.44M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Codiak BioSciences, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 40 | 27 | −13 |
| Shares | 14.6M | 8.24M | −6.31M (−43.3%) |
| Value | $5.76M | $1.44M | −$4.32M (−75.0%) |
New holders (1)
Institutions that held Codiak BioSciences, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 30,566 | $5.00K | 0.00% |
Sold out (14)
Institutions that held Codiak BioSciences, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Alyeska Investment Group, L.P. | 666,891 | $265.2K |
| Renaissance Technologies LLC | 300,852 | $120.0K |
| Artal Group S.A. | 200,000 | $80.0K |
| BlackRock Inc. | 187,833 | $74.7K |
| Victory Capital Management Inc | 69,102 | $27.5K |
| State Street Corp | 48,349 | $19.2K |
| Prudential Financial Inc | 47,800 | $19.0K |
| Two Sigma Investments, LP | 29,453 | $11.7K |
| Northern Trust Corp | 26,131 | $10.4K |
| Two Sigma Advisers, LP | 13,600 | $5.41K |
| Belpointe Asset Management LLC | 2,506 | $996 |
| Citigroup Inc | 449 | $179 |
| Group One Trading, L.P. | 22 | $9 |
| Simplex Trading, LLC | 152 | $0 |